Skip to main content

Table 2 Comparison of patient characteristics in the first three COVID waves

From: Intermittent body composition analysis as monitoring tool for muscle wasting in critically ill COVID-19 patients

Wave

Means

 

1

2

3

p value

n = 15

n = 22

n = 17

Survival (%)

0.87

0.27

0.65

0.001

Hospitalization (days)

105.93

51.23

95.12

0.001

ICU stay (days)

90.80

43.05

71.18

0.005

sPEEP (cmH2O)

16.71

15.73

14.59

0.313

pPeak (cmH2O)

30.57

29.73

30.35

0.877

RMV (l/min)

8.32

6.66

7.54

0.248

RR

18.57

18.09

20.41

0.331

Dexamethasone

0.43

0.95

0.82

0.001

Tocilizumab

0.00

0.27

0.29

0.084

NMBA

0.43

0.50

0.76

0.127

First loss (%/day)

2.97%

3.58%

1.72%

0.247

Max loss (%/day)

4.58%

4.81%

3.94%

0.740

Overall loss (%/day)

1.47%

2.56%

1.42%

0.059

  1. Significant values are printed in bold